Month: July 2016

Seminal ARC Manuscript Published
Amyloidosis Research Consortium Announces Publication of Seminal Manuscript in Peer-Reviewed Journal Leukemia Encouraging Use of NT-proBNP as Endpoint in Clinical Trials. International AL amyloidosis expert community agrees N-terminal pro-brain natriuretic peptide (NT-proBNP) is analytically validated and clinically qualified to be...
Read More
Report from International Symposium on Amyloidosis
The 2016 International Symposium on Amyloidosis was held in Uppsala, Sweden in early July. Over the years the meeting has grown in size and it was impressive to see over 400 scientists and experts come together to spend three days...
Read More
Focus on Heart Failure Nurses
“Save one life and you’re a hero, save one hundred lives and you’re a nurse.” This anonymous quote highlights the important role of nurses in the medical profession. With this in mind, ARC participated in the American Association of Heart...
Read More
ARC Educational Power Pack for Healthcare Professionals
Please Note: This information was provided on July 2016. As we update our internal documents, we will share the newest information. As part of our mission to improve early diagnosis and accelerate amyloidosis treatment, ARC has developed a set of...
Read More

AMYLOIDOSIS RESEARCH CONSORTIUM, INC.
320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170
arc@arci.org

ARC is a 501(c)(3) nonprofit organization